TSXV:SQD.H - Post by User
Post by
FactFinder1994on Apr 05, 2022 1:43pm
128 Views
Post# 34577463
“This is out-of-this-world game-changing.” - Shaf Keshavjee
“This is out-of-this-world game-changing.” - Shaf Keshavjee Over the years ahead UHN will replicate with other organs what has successfully taken place with Lungs. With the assistance of multiplex diagnostics from SQI, utilization goes from between 1 or 2 in 5, to more than 4 in 5. This is a significant win for all involved and represents a massive opportunity for SQI. Don't expect SQI to connect the dots, you will be waiting a long time. On page 19 of the most recent Investor Presentation a quiet update to the revenue per donor lung was updated to $10K in kit proceeds. At one time it was suggested it would be closer to $4K. Clearly the success allowed for premium pricing. The implications in revenue for participating transplant centers is in the billions of dollars given the million dollar price tag per Lung transplant. SQI's 1% really adds up $10K at a time, especially as it is rolled out to top global centers that follow Toronto's protocols.
This stock however is controled by few, rather than a wider audience of integrity that scale/diverse volume brings. There are those that stand to benefit and I get the feeling they tend to escort negative sentiment when ever they can. The company needs to make a constructive effort to share the story with a wider audience, as clearly not sharing the story allows a few with an agenda to determine value, rather than an informed market of integrity.
https://www.sshrc-crsh.gc.ca/funding-financement/nfrf-fnfr/stories-histoires/2022/transplantation-eng.aspx